| Nov 1 |
U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
|
| Oct 31 |
AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
|
| Oct 31 |
3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
|
| Oct 31 |
China Widens AstraZeneca Probe as Country Boss Investigated
|
| Oct 30 |
AstraZeneca executive under investigation by police in China
|
| Oct 30 |
AstraZeneca China president under investigation by Chinese authorities
|
| Oct 30 |
AstraZeneca president faces investigation in China
|
| Oct 29 |
Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?
|
| Oct 29 |
Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase
|
| Oct 29 |
EC approves AstraZeneca’s Fasenra for EGPA treatment
|
